|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.7070 - 0.7380|
|52 Week Range||0.3279 - 1.1558|
|Beta (3Y Monthly)||2.53|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
OTCQX: RDDTF) is pleased to announce that it has appointed Ms. Jocelyne F. Lafrenière and Mr. Yves Gougoux to its Board of Directors, effective upon approval by Health Canada. “We are delighted to be bringing these two very accomplished individuals onto our Board of Directors, and expanding our Board in the process”, commented Frank Ferlaino, Chairman of Radient’s Board of Directors. “As Radient continues to grow its operations globally by entering into new geographical markets and increasing its market presence in highly competitive industries, the expertise and knowledge that both Ms. Lafrenière and Mr. Gougoux bring to the Company will be invaluable.
OTCQX: RDDTF) is pleased to announce that it has appointed Mr. Adrian Marshall and Mr. James Blakelock to the joint role of Executive Vice President, Corporate Strategy and Planning, and Mr. Bill Wasson to the role of Senior Vice President, Capital Markets and Investor Relations. Working closely with Radient’s existing Management Team and Board of Directors, they will be instrumental in developing, driving and communicating the Company’s corporate strategy and global expansion.
EDMONTON, Alberta, March 14, 2019 -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF) is pleased to announce that it has begun production.
The reviewed financial statements and Management’s Discussion & Analysis are available under the Company’s profile at www.SEDAR.com. This reserve of cash will allow Radient to execute on its previously announced physical and operational expansions in Edmonton and Germany (summarized in greater detail below). Radient’s current total debt is CAD $10M and the Company was granted its Standard Processing License from Health Canada on February 1, 2019.
EDMONTON, Alberta, Feb. 22, 2019 -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF) is pleased to announce it has filed an additional 17.
Canadian cannabis producer Aurora Cannabis Inc (NYSE: ACB) announced Monday that Health Canada has granted its extraction technology partner Radient Technologies Inc (OTC: RDDTF) a standard processing license. Radient identified a process to extract cannabis and hemp at large-scale volumes without risking the quality of the plant, according to Aurora. Aurora said it became aware of Radient's technology and its potential to disrupt the market in 2016.
OTCQX: RDDTF) announces today the following changes to its Board of Directors. Radient believes Mr. Cleiren will be a valuable addition to the Company as it moves forward with the commercial production of cannabinoid extracts and products, along with the global expansion of its operations. Concurrent to the appointment of Mr. Cleiren to Radient’s Board of Directors, the Company also announces that Mr. Terry Booth is stepping down from Radient’s Board of Directors, effective today.
OTCQX: RDDTF) is pleased to announce it has received its Standard Processing License from Health Canada under the new Cannabis Act regulations, which came into force on October 17, 2018. Processing of cannabis biomass in order to extract cannabinoids including CBD and THC will now begin at Radient’s recently expanded manufacturing facility (“Edmonton I Facility”) located at 4035 101 St NW in Edmonton, Alberta. This will create new revenue streams for the Company, as it begins supplying premium grade cannabis extracts and cannabinoid ingredients to its partners, including Aurora Cannabis Inc.
NEW YORK and TORONTO , Jan. 11, 2019 /PRNewswire/ -- The Canadian Securities Exchange (CSE), a Canadian listing exchange recognized as a Qualified Foreign Exchange in the U.S., Kapoor Kapital, and OTC ...
OTCQX: RDDTF) is pleased to announce that it has now filed an additional 9 provisional patent applications with the United States Patent and Trademark Office (the “USPTO”), bringing the total number of patent applications filed by the Company in 2018 to 40. The inventions covered in these patent applications relate to methods and systems for improving the safety, potency, flavour, and experience of cannabinoid extracts used in the manufacturing of food & beverage products.
OTCQX: RDDTF) is pleased to announce that its common shares commenced trading today on the OTCQX Best Market under the symbol “RDDTF”. Radient’s common shares will continue trading on the TSX Venture Exchange under the symbol “RTI”. Dorsey & Whitney LLP acted as the Company’s OTCQX Best Market sponsor and advisor.
NEW YORK , Dec. 18, 2018 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced Radient Technologies Inc. (TSX-V: RTI; ...